BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6897931)

  • 21. [Measurement of plasma 1,25 dihydrovitamin D. Normal and pathological values in adults (author's transl)].
    Ulmann A; Lair M; Bader C; Funck-Brentano JL
    Nouv Presse Med; 1981 Apr; 10(17):1393-5. PubMed ID: 7015271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children.
    Garabedian M; Silve C; Levy-Bentolila D; Bourdeau A; Ulmann A; Nguyen TM; Lieberherr M; Broyer M; Balsan S
    Kidney Int; 1981 Sep; 20(3):403-10. PubMed ID: 7029120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
    LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
    N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic metabolic acidosis increases the serum concentration of 1,25-dihydroxyvitamin D in humans by stimulating its production rate. Critical role of acidosis-induced renal hypophosphatemia.
    Krapf R; Vetsch R; Vetsch W; Hulter HN
    J Clin Invest; 1992 Dec; 90(6):2456-63. PubMed ID: 1469097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.
    Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH
    J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and metabolic clearance of 1,25-dihydroxyvitamin D in men: effect of advancing age.
    Halloran BP; Portale AA; Lonergan ET; Morris RC
    J Clin Endocrinol Metab; 1990 Feb; 70(2):318-23. PubMed ID: 2298850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum.
    Parviainen MT; Savolainen KE; Alhava EM; Mäenpää PH
    Ann Clin Res; 1981 Feb; 13(1):26-33. PubMed ID: 6972726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans.
    Adams ND; Garthwaite TL; Gray RW; Hagen TC; Lemann J
    J Clin Endocrinol Metab; 1979 Oct; 49(4):628-30. PubMed ID: 573283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentrations of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25,26-dihydroxyvitamin D in the first year of life.
    Markestad T
    J Clin Endocrinol Metab; 1983 Oct; 57(4):755-9. PubMed ID: 6604063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
    Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
    Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced 2,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D in epileptic patients receiving chronic combined anticonvulsant therapy.
    Christensen CK; Lund B; Lund BJ; Sørensen OH; Nielsen HE; Mosekilde L
    Metab Bone Dis Relat Res; 1981; 3(1):17-22. PubMed ID: 6973685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D kinetics in vivo: effect of 1,25-dihydroxyvitamin D administration.
    Halloran BP; Castro ME
    Am J Physiol; 1989 May; 256(5 Pt 1):E686-91. PubMed ID: 2785765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of parathyroidectomy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism.
    Bone HG; Zerwekh JE; Haussler MR; Pak CY
    J Clin Endocrinol Metab; 1979 May; 48(5):877-9. PubMed ID: 429532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration.
    Bouillon R; Van Assche FA; Van Baelen H; Heyns W; De Moor P
    J Clin Invest; 1981 Mar; 67(3):589-96. PubMed ID: 6894152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of vitamin D metabolites in anephric subjects.
    Jongen MJ; van der Vijgh WJ; Lips P; Netelenbos JC
    Nephron; 1984; 36(4):230-4. PubMed ID: 6608697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with various types of renal disease.
    Kano K; Nonoda A; Yoneshima H; Suda T
    Clin Nephrol; 1980 Dec; 14(6):274-9. PubMed ID: 6970645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.
    Christiansen C; Rødbro P; Naestoft J; Christensen MS
    Clin Endocrinol (Oxf); 1981 Sep; 15(3):237-42. PubMed ID: 6273028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.
    Zerwekh JE; Pak CY; Kaplan RA; McGuire JL; Upchurch K; Breslau N; Johnson R
    J Clin Endocrinol Metab; 1980 Aug; 51(2):381-6. PubMed ID: 6893205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.